Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Hott DouglasChief Financial Officer |  SNAPSnap IncOpen-market sale · 10b5-1 plan | SELL | $650K 114.7K sh | May 20, 2026 |
| 17 | Marcus CatherineDirector |  TILEINTERFACE INCGrant or award | A | — 4,461 sh | May 20, 2026 traded May 19, 2026 |
| 17 | Yan MingDirector, CHIEF TECHNOLOGY OFFICER | CTKBCytek Biosciences, Inc. Option exercise | M | — 4,908 sh | May 20, 2026 traded May 18, 2026 |
| 16 | Iriarte Esteban CDirector |  ADARRAY DIGITAL INFRASTRUCTURE, INC.Grant or award | A | $95K 1,873 sh | May 20, 2026 traded May 19, 2026 |
| 16 | Holme TimothyCHIEF TECHNOLOGY OFFICER |  QSQuantumScape CorpOpen-market sale · 10b5-1 plan | SELL | $257K 34.3K sh | May 20, 2026 traded May 20, 2026 |
| 16 | Arora SumeetChief Product Officer |  TDCTERADATA CORP /DE/Open-market sale · 10b5-1 plan | SELL | $495K 15.0K sh | May 20, 2026 traded May 19, 2026 |
| 16 | Valente ManuelaChief People Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $1,747 380 sh | May 20, 2026 traded May 19, 2026 |
| 16 | PWP VoteCo Professionals LPDirector |  PWPPerella Weinberg PartnersOther acquisition or disposition | J | $38K 1.91M sh | May 20, 2026 traded May 18, 2026 |
| 15 | Kharsansky AlanChief Technology Officer |  SATLSatellogic Inc.Option exercise | M | — 87.1K sh | May 20, 2026 traded May 14, 2026 |
| 15 | Ederer JohnChief Financial Officer | TDCTERADATA CORP /DE/ Tax withholding | F | $438K 13.4K sh | May 20, 2026 traded May 18, 2026 |
| 14 | Maheshwari AnshulChief Financial Officer |  SIBNSI-BONE, Inc.Open-market sale | SELL | $36K 2,477 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $538K 2,320 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $541K 2,400 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $530K 2,375 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $257K 1,158 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $426K 1,848 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $520K 2,356 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $421K 1,996 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $391K 1,782 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $710K 3,247 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Sander Dale A.CFO and Chief Corp. Dev. Off |  HUMAHumacyte, Inc.Open-market sale · 10b5-1 plan | SELL | $41K 45.9K sh | May 20, 2026 traded May 18, 2026 |
| 14 | Parikh Shamik JChief Medical Officer | HUMAHumacyte, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 45.9K sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $280K 1,189 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Maheshwari AnshulChief Financial Officer | SIBNSI-BONE, Inc. Open-market sale | SELL | $32K 2,189 sh | May 20, 2026 traded May 18, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $662K 2,841 sh | May 20, 2026 traded May 18, 2026 |
| 13 | McCombe William D.Chief Financial Officer | CTKBCytek Biosciences, Inc. Option exercise | M | — 6,320 sh | May 20, 2026 traded May 18, 2026 |
| 13 | Barnett ValerieCHIEF LEGAL OFFICER | CTKBCytek Biosciences, Inc. Option exercise | M | — 7,250 sh | May 20, 2026 traded May 18, 2026 |
| 13 | Patton Charles R.Director |  CTRICenturi Holdings, Inc.Grant or award | A | — 4,067 sh | May 20, 2026 traded May 19, 2026 |
| 13 | Barnett ValerieCHIEF LEGAL OFFICER | CTKBCytek Biosciences, Inc. Option exercise | M | — 5,156 sh | May 20, 2026 traded May 18, 2026 |
| 13 | Yan MingDirector, CHIEF TECHNOLOGY OFFICER | CTKBCytek Biosciences, Inc. Option exercise | M | — 3,683 sh | May 20, 2026 traded May 18, 2026 |
| 13 | Busque PhilippeSVP, GLOBAL SALES AND SERVICES | CTKBCytek Biosciences, Inc. Option exercise | M | — 2,416 sh | May 20, 2026 traded May 18, 2026 |
| 13 | Jiang WenbinDirector, PRESIDENT AND CEO | CTKBCytek Biosciences, Inc. Option exercise | M | — 14.7K sh | May 20, 2026 traded May 18, 2026 |
| 13 | McCombe William D.Chief Financial Officer | CTKBCytek Biosciences, Inc. Option exercise | M | — 8,700 sh | May 20, 2026 traded May 18, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $2,798 608 sh | May 20, 2026 traded May 19, 2026 |
| 13 | Haller Karen SDirector | CTRICenturi Holdings, Inc. Grant or award | A | — 4,067 sh | May 20, 2026 traded May 19, 2026 |
| 13 | Kasarda John D.Director |  ODFLOLD DOMINION FREIGHT LINE, INC.Grant or award | A | — 859 sh | May 20, 2026 traded May 20, 2026 |
| 13 | Busque PhilippeSVP, GLOBAL SALES AND SERVICES | CTKBCytek Biosciences, Inc. Option exercise | M | — 1,473 sh | May 20, 2026 traded May 18, 2026 |
| 13 | Busque PhilippeSVP, GLOBAL SALES AND SERVICES | CTKBCytek Biosciences, Inc. Option exercise | M | — 2,416 sh | May 20, 2026 traded May 18, 2026 |
| 13 | Stallings Wendy T.Director | ODFLOLD DOMINION FREIGHT LINE, INC. Grant or award | A | — 859 sh | May 20, 2026 traded May 20, 2026 |
| 13 | Aaholm Sherry ADirector | ODFLOLD DOMINION FREIGHT LINE, INC. Grant or award | A | — 859 sh | May 20, 2026 traded May 20, 2026 |